ABBV.CI
AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1 · BCBA:ABBV.CI
47,920.00 ARS−920.00 −1.88%
AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1 (BCBA:ABBV.CI) last traded at 47,920.00 ARS, down 1.88% on the day. Over the past year the stock is up 46.72%. Its 52-week range is 29,500.00 to 49,100.00. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open48,640.00
Day range47,540.00 – 48,980.00
52-week range29,500.00 – 49,100.00
Volume217
Average volume (10 days)173
Market cap (USD)521.11 B
P/E5.67
EPS (TTM) (USD)5.53
Dividend yield1.37%
Beta (1 year)−0.1473
Revenue (TTM) (USD)62.35 B
Employees57.00 K
Performance
−0.58%1 week
+13.29%1 month
+24.02%3 months
+56.09%6 months
+36.52%Year to date
+46.72%1 year
Technical reading
Bullish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- AbbVie Stocks Decline 2.3% With RBC Target Increase Backing Its Immunology TransitionGuruFocus · 02 Nov 2026
- AbbVie Price Target Raised to $346.00/Share From $310.00 by Morgan StanleyDow Jones Newswires · 02 Nov 2026
- Morgan Stanley maintains AbbVie at Overweight, raises price target to $346 from $310TradingView · 02 Nov 2026
- AbbVie Price Target Raised to $322.00/Share From $288.00 by GuggenheimDow Jones Newswires · 02 Nov 2026
- Guggenheim maintains AbbVie at Buy, raises price target to $322 from $288TradingView · 02 Nov 2026
- Brise Pharmaceuticals Announces Global License Agreement With Abbvie To Advance The Next-Generation Of Migraine TherapiesReuters · 02 Nov 2026
- ABBV Q3 Earnings Call Highlights Raised Outlook and Pipeline ProgressZacks · 02 Nov 2026
- AbbVie Price Target Raised to $340.00/Share From $300.00 by Wells FargoDow Jones Newswires · 02 Nov 2026
Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.